Colette Dejong, MD

Title(s)Volunteer Clinical Instructor, Medicine
SchoolSchool of Medicine
Address505 Parnassus Avenue, #001
San Francisco CA 94117
Phone415-353-7900
PronounsShe/Her/Hers
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. EARLY RESULTS OF THE COMBO-HF-X PILOT CROSSOVER TRIAL: DELIVERING QUADRUPLE THERAPY FOR HEART FAILURE WITH REDUCED EJECTION FRACTION IN A SINGLE CAPSULE IN A SAFETY NET HEALTHCARE SYSTEM. Journal of the American College of Cardiology. 2025 Apr 1; 85(12):1517. DeJong DC, Durstenfeld DM, Davis DJ, Wang WC, Levkova LM, Schaffer SV, Riley RE, Huffman HM, Hickey HM, Shade SS, Chen CJ, Steward SW, Kazi KD, Grochowski GJ, Zier ZL, Moreau MN, Sandhu SA, Heidenreich HP, Agarwal AA, Hsue HP. .
      View in: Publisher Site   Mentions:
    2. Prototyping and Manufacturing of Customized Over-Encapsulated Polypills for Heart Failure With Reduced Ejection Fraction in a Safety-Net Health Care System. J Card Fail. 2025 May; 31(5):868-871. Dejong C, Durstenfeld MS, Davis JD, Wang CS, Chen JC, Kazi DS, Hickey MD, Grochowski J, Steward WT, Riley ED, Zier LS, Moreau N, Huffman MD, Sandhu AT, Heidenreich PA, Agarwal A, Hsue PY. PMID: 40169092.
      View in: PubMed   Mentions:    Fields:    
    3. Delivering guideline-directed medical therapy for heart failure with reduced ejection fraction as an over-encapsulated polypill: rationale and protocol for the COMBO-HF-X pilot crossover randomised clinical trial. BMJ Open. 2025 Mar 21; 15(3):e093663. DeJong C, Durstenfeld MS, Davis JD, Wang CS, Riley ED, Huffman MD, Hickey MD, Shade SB, Chen JC, Kazi DS, Grochowski J, Steward WT, Zier LS, Moreau N, Sandhu AT, Heidenreich PA, Agarwal A, Hsue PY. PMID: 40118491; PMCID: PMC11950958.
      View in: PubMed   Mentions:    Fields:    Translation:CTClinical Trials
    4. Direct-to-Physician Marketing and Uptake of Optimal Medical Therapy for Heart Failure With Reduced Ejection Fraction. JACC Heart Fail. 2025 Mar 12. DeJong C, Inoue K, Durstenfeld MS, Agarwal A, Chen JC, Tseng CW, Dudley RA, Hsue PY, Kazi DS. PMID: 40117391.
      View in: PubMed   Mentions:    Fields:    
    5. New and future heart failure drugs. Nat Cardiovasc Res. 2024 Dec; 3(12):1389-1407. Haghighat L, DeJong C, Teerlink JR. PMID: 39632985.
      View in: PubMed   Mentions: 2  Translation:HumansAnimals
    6. Stakeholder Perspectives on a Heart Failure With Reduced Ejection Fraction Polypill: A Multi-Center Mixed Methods Study. Circ Cardiovasc Qual Outcomes. 2024 Nov; 17(11):e011121. Chen JC, DeJong C, Agarwal M, Hairston AM, Durstenfeld MS, McKay V, Huffman MD, Hsue PY, Agarwal A. PMID: 39503613; PMCID: PMC11576259.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. DIRECT-TO-PHYSICIAN MARKETING AND ADOPTION OF GUIDELINE-DIRECTED MEDICAL THERAPY IN MEDICARE PART D. Journal of the American College of Cardiology. 2024 Apr 1; 83(13):611. DeJong DC, Inoue IK, Durstenfeld DM, Agarwal AA, Chen CJ, Tseng TC, Dudley DR, Hsue HP, Kazi KD. .
      View in: Publisher Site   Mentions:
    8. PATIENT AND PROVIDER PERSPECTIVES ON A POLYPILL FOR HEART FAILURE WITH REDUCED EJECTION FRACTION. Journal of the American College of Cardiology. 2024 Apr 1; 83(13):393. Chen CJ, DeJong DC, Hairston HA, Durstenfeld DM, Hsue HP, Huffman HM, Agarwal AA. .
      View in: Publisher Site   Mentions:
    9. Abstract 15872: Development and External Validation of a De Novo Simulation Model to Inform Implementation Strategies for Guideline-Directed Medical Therapy of Heart Failure With Reduced Ejection Fraction. Circulation. 2023 Nov 7; 148(Suppl_1). Foote FJ, Pandey PA, Agarwal AA, Bellows BB, DeJong DC, Hsue HP, Kazi KD. .
      View in: Publisher Site   Mentions:
    10. The Inflation Reduction Act and Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Disease. J Am Coll Cardiol. 2023 05 30; 81(21):2103-2111. Kazi DS, DeJong C, Chen R, Wadhera RK, Tseng CW. PMID: 37225364.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    11. IMPACT OF THE $35 INSULIN PROGRAM ON OUT-OF-POCKET COSTS UNDER MEDICARE PART D. Journal of the American College of Cardiology. 2023 Mar 1; 81(8):1869. Dejong DC, Chen CR, Masuda MC, Tseng TC. .
      View in: Publisher Site   Mentions:
    12. PROJECTED IMPACT OF THE INFLATION REDUCTION ACT ON OUT-OF-POCKET DRUG COSTS FOR MEDICARE PART D BENEFICIARIES WITH CARDIOVASCULAR DISEASE. Journal of the American College of Cardiology. 2023 Mar 1; 81(8):273. Kazi KD, Dejong DC, Wadhera WR, Chen CR, Tseng TC. .
      View in: Publisher Site   Mentions:
    13. THE INFLATION REDUCTION ACT WILL CHANGE WHO PAYS FOR CARDIOVASCULAR DRUGS UNDER MEDICARE PART D. Journal of the American College of Cardiology. 2023 Mar 1; 81(8):1671. Kazi KD, DeJong DC, Chen CR, Tseng TC. .
      View in: Publisher Site   Mentions:
    14. Spending on Insulin by U.S. Payers and Patients From 2008 to 2017. Diabetes Care. 2022 11 01; 45(11):e163-e164. Chiu N, Aggarwal R, Hernandez I, Wadhera R, Dejong C, Tseng CW, Yeh RW, Kazi DS. PMID: 36041194.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. A Pilot Program to Teach Pharmacy Students Practical Skills to Navigate Drug Insurance Benefits. Pharmacy (Basel). 2022 Jan 27; 10(1). Masuda C, Huynh T, Wong V, DeJong C, Tseng CW. PMID: 35202072; PMCID: PMC8878890.
      View in: PubMed   Mentions:
    16. Patients' Compliance With Quarantine Requirements for Exposure or Potential Symptoms of COVID-19. Hawaii J Health Soc Welf. 2021 11; 80(11):276-282. Tseng CW, Roh Y, DeJong C, Kanagusuku LN, Soin KS. PMID: 34765987; PMCID: PMC8571817.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsPHPublic Health
    17. Association Between Industry Marketing Payments and Prescriptions for PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors in the United States. Circ Cardiovasc Qual Outcomes. 2021 05; 14(5):e007521. Inoue K, Figueroa JF, DeJong C, Tsugawa Y, Orav EJ, Shen C, Kazi DS. PMID: 33966446.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    18. Trends in the Use of Angiotensin-Converting Enzyme Inhibitor and Angiotensin-II Receptor Blocker Among United States Adults From 1999 to 2018. Endocr Pract. 2021 May; 27(5):503-504. Inoue K, DeJong C, Nangaku M. PMID: 33934755.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Deferral of Care for Serious Non-COVID-19 Conditions: A Hidden Harm of COVID-19. JAMA Intern Med. 2021 02 01; 181(2):274. DeJong C, Katz MH, Covinsky K. PMID: 33104166.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    20. Out-of-Pocket Costs for Novel Guideline-Directed Diabetes Therapies Under Medicare Part D. JAMA Intern Med. 2020 12 01; 180(12):1696-1699. DeJong C, Masuda C, Chen R, Kazi DS, Dudley RA, Tseng CW. PMID: 32926091; PMCID: PMC7490744.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    21. Inclusion Across the Lifespan in Cardiovascular Trials-A Long Road Ahead. JAMA Intern Med. 2020 11 01; 180(11):1533-1534. DeJong C, Covinsky K. PMID: 32897305.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. Multivessel or Culprit Vessel-Only Percutaneous Coronary Intervention for Patients With Acute Myocardial Infarction and Cardiogenic Shock: Real-World Evidence in Support of CULPRIT-SHOCK. JAMA Intern Med. 2020 10 01; 180(10):1280-1283. DeJong C, Redberg RF. PMID: 32833000.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm. JAMA Intern Med. 2020 08 01; 180(8):1118-1119. DeJong C, Wachter RM. PMID: 32347894.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCellsPHPublic Health
    24. An Ethical Framework for Allocating Scarce Inpatient Medications for COVID-19 in the US. JAMA. 2020 Jun 16; 323(23):2367-2368. DeJong C, Chen AH, Lo B. PMID: 32412580.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsPHPublic Health
    25. Addressing Mistreatment in Medical Education. JAMA Intern Med. 2020 05 01; 180(5):665. Thakkar AB, Dejong C, Katz MH. PMID: 32091570.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Continuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Face of Kidney Disease Progression-Safe and Possibly Life Saving. JAMA Intern Med. 2020 05 01; 180(5):727. DeJong C, Grant RW. PMID: 32150238.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    27. Disclosure of Article Funding and Conflicts of Interest in High-Impact Clinical Journals. J Gen Intern Med. 2020 04; 35(4):1345-1347. Anderson TS, DeJong C, Good CB, Gellad WF. PMID: 32016701; PMCID: PMC7174528.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Shining a Light on Industry Payments to Health Care Professionals Who Are Not Physicians. JAMA Intern Med. 2019 Oct 01; 179(10):1432-1433. DeJong C, Steinbrook R. PMID: 31180496.
      View in: PubMed   Mentions:    Fields:    
    29. Assessment of National Coverage and Out-of-Pocket Costs for Sacubitril/Valsartan Under Medicare Part D. JAMA Cardiol. 2019 08 01; 4(8):828-830. DeJong C, Kazi DS, Dudley RA, Chen R, Tseng CW. PMID: 31290933; PMCID: PMC6624798.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    30. Supplemental Security Income and the Health of Low-Income Adults. JAMA Intern Med. 2019 06 01; 179(6):843-844. DeJong C, Katz MH. PMID: 30933212.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. Electrocardiographic Harbingers of Ventricular Tachycardia Arrest-A Moment of Pause. JAMA Intern Med. 2019 02 01; 179(2):249-251. DeJong C, Nishtala A, Goldschlager N. PMID: 30477008.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Validation of Prediction Models for Critical Care Outcomes Using Natural Language Processing of Electronic Health Record Data. JAMA Netw Open. 2018 12 07; 1(8):e185097. Marafino BJ, Park M, Davies JM, Thombley R, Luft HS, Sing DC, Kazi DS, DeJong C, Boscardin WJ, Dean ML, Dudley RA. PMID: 30646310; PMCID: PMC6324323.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    33. Continuing Problems With Financial Conflicts of Interest and Clinical Practice Guidelines. JAMA Intern Med. 2018 12 01; 178(12):1715. DeJong C, Steinbrook R. PMID: 30383081.
      View in: PubMed   Mentions: 3     Fields:    
    34. Nationwide Coverage and Cost-Sharing for PCSK9 Inhibitors Among Medicare Part D Plans. JAMA Cardiol. 2017 10 01; 2(10):1164-1166. Kazi DS, Lu CY, Lin GA, DeJong C, Dudley RA, Chen R, Tseng CW. PMID: 28903137; PMCID: PMC5815006.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    35. MEDICARE PART D—COST BURDEN OF INHALED DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE. Innovation in Aging. 2017 Jul 1; 1(suppl_1):147-147. Tseng TC, Yazdany YJ, Dudley DR, Dejong DC, Kazi KD, Chen CR, Lin LG. .
      View in: Publisher Site   Mentions:
    36. Reconsidering Physician-Pharmaceutical Industry Relationships. JAMA. 2017 05 02; 317(17):1772-1773. DeJong C, Dudley RA. PMID: 28464124.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    37. Medicare Part D Plans' Coverage and Cost-Sharing for Acute Rescue and Preventive Inhalers for Chronic Obstructive Pulmonary Disease. JAMA Intern Med. 2017 04 01; 177(4):585-588. Tseng CW, Yazdany J, Dudley RA, DeJong C, Kazi DS, Chen R, Lin GA. PMID: 28241217; PMCID: PMC6822611.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    38. Important Distinctions Concerning Pharmaceutical Company-Sponsored Meals and Prescribing Patterns-Reply. JAMA Intern Med. 2016 12 01; 176(12):1881. DeJong C, Tseng CW, Dudley RA. PMID: 27918818.
      View in: PubMed   Mentions:    Fields:    
    39. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries. JAMA Intern Med. 2016 08 01; 176(8):1114-1122. DeJong C, Aguilar T, Tseng CW, Lin GA, Boscardin WJ, Dudley RA. PMID: 27322350.
      View in: PubMed   Mentions: 157     Fields:    Translation:Humans
    40. Variation in Quality of Urgent Health Care Provided During Commercial Virtual Visits. JAMA Intern Med. 2016 05 01; 176(5):635-42. Schoenfeld AJ, Davies JM, Marafino BJ, Dean M, DeJong C, Bardach NS, Kazi DS, Boscardin WJ, Lin GA, Duseja R, Mei YJ, Mehrotra A, Dudley RA. PMID: 27042813; PMCID: PMC6842573.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    41. Incorporating a New Technology While Doing No Harm, Virtually. JAMA. 2015 Dec 08; 314(22):2351-2. DeJong C, Lucey CR, Dudley RA. PMID: 26647252.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    42. Websites that offer care over the Internet: is there an access quality tradeoff? JAMA. 2014 Apr 02; 311(13):1287-8. DeJong C, Santa J, Dudley RA. PMID: 24691602.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    43. Short communication: new HIV infections at Southern New England academic institutions: implications for prevention. AIDS Res Hum Retroviruses. 2013 Jan; 29(1):25-9. Chan PA, Kazi S, Rana A, Blazar I, Dejong CC, Mayer KH, Huard TK, Carleton K, Gillani F, Alexander N, Parillo Z, Flanigan TP, Kantor R. PMID: 22724920; PMCID: PMC3537304.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsPHPublic Health
    Colette's Networks
    Concepts (153)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (25)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.